{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:06:12Z","timestamp":1777493172300,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s10038-019-0612-6","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T06:37:28Z","timestamp":1557815848000},"page":"767-773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["PALB2 c.2257C&gt;T truncating variant is a Greek founder and is associated with high breast cancer risk"],"prefix":"10.1038","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3407-4561","authenticated-orcid":false,"given":"Andromachi","family":"Vagena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrto","family":"Papamentzelopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3369-2360","authenticated-orcid":false,"given":"Despoina","family":"Kalfakakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagoula","family":"Kollia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Psyrri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9865-0682","authenticated-orcid":false,"given":"Paraskevi","family":"Apostolou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0470-0309","authenticated-orcid":false,"given":"Irene","family":"Konstantopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drakoulis","family":"Yannoukakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2751-2332","authenticated-orcid":false,"given":"Florentia","family":"Fostira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"612_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ng1947","volume":"39","author":"S Reid","year":"2007","unstructured":"Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39:162\u20134.","journal-title":"Nat Genet"},{"key":"612_CR2","doi-asserted-by":"publisher","first-page":"10312","DOI":"10.1093\/nar\/gks807","volume":"40","author":"R Buisson","year":"2012","unstructured":"Buisson R, Masson JY. PALB2 self-interaction controls homologous recombination. Nucleic Acids Res. 2012;40:10312\u201323.","journal-title":"Nucleic Acids Res."},{"key":"612_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/cncr.28504","volume":"120","author":"PH Fernandes","year":"2014","unstructured":"Fernandes PH, Saam J, Peterson J, Hughes E, Kaldate R, Cummings S, et al. Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer. Cancer. 2014;120:963\u20137.","journal-title":"Cancer."},{"key":"612_CR4","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.1073\/pnas.0701724104","volume":"104","author":"M Tischkowitz","year":"2007","unstructured":"Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, et al. Analysis of PALB2\/FANCN-associated breast cancer families. Proc Natl Acad Sci USA. 2007;104:6788\u201393.","journal-title":"Proc Natl Acad Sci USA."},{"key":"612_CR5","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1158\/0008-5472.CAN-10-1012","volume":"70","author":"M Tischkowitz","year":"2010","unstructured":"Tischkowitz M, Xia B. PALB2\/FANCN: recombining cancer and Fanconi anemia. Cancer Res. 2010;70:7353\u20139.","journal-title":"Cancer Res."},{"key":"612_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007;39:165\u20137.","journal-title":"Nat Genet."},{"key":"612_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371:497\u2013506.","journal-title":"N Engl J Med."},{"issue":"1","key":"612_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaoncol.2018.2956","volume":"5","author":"Hsiao-Mei Lu","year":"2019","unstructured":"Lu HM, Li S, Black MH, Lee S, Hoiness R, Wu S, et al. Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing. JAMA Oncol. 2018. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2018.2956\n                    \n                  .","journal-title":"JAMA Oncology"},{"key":"612_CR9","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3:1190\u20136.","journal-title":"JAMA Oncol."},{"key":"612_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cam4.1376","volume":"7","author":"J Hauke","year":"2018","unstructured":"Hauke J, Horvath J, Gross E, Gehrig A, Honisch E, Hackmann K, et al. Gene panel testing of 5589 BRCA1\/2-negative index patients with breast cancer in a routine diagnostic setting: results of the german consortium for hereditary breast and ovarian cancer. Cancer Med. 2018;7:1349\u201358.","journal-title":"Cancer Med."},{"key":"612_CR11","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/s41436-018-0005-9","volume":"20","author":"L Castera","year":"2018","unstructured":"Castera L, Harter V, Muller E, Krieger S, Goardon N, Ricou A, et al. Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families. Genet Med. 2018;20:1677\u201386.","journal-title":"Genet Med."},{"key":"612_CR12","doi-asserted-by":"publisher","unstructured":"Ramus SJ, Song H, Dicks E, Tyrer JP, Rosenthal AN, Intermaggio MP, et al. Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer. J Natl Cancer Inst. 2015. \n                    https:\/\/doi.org\/10.1093\/jnci\/djv214\n                    \n                  .","DOI":"10.1093\/jnci\/djv214"},{"key":"612_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10689-016-9919-z","volume":"16","author":"J Kotsopoulos","year":"2017","unstructured":"Kotsopoulos J, Sopik V, Rosen B, Fan I, McLaughlin JR, Risch H, et al. Frequency of germline PALB2 mutations among women with epithelial ovarian cancer. Fam Cancer. 2017;16:29\u201334.","journal-title":"Fam Cancer."},{"key":"612_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, Gulsuner S, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2:482\u201390.","journal-title":"JAMA Oncol."},{"key":"612_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/gim.2014.153","volume":"17","author":"DB Zhen","year":"2015","unstructured":"Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, et al. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2015;17:569\u201377.","journal-title":"Genet Med."},{"key":"612_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cancergen.2016.03.003","volume":"209","author":"M Borecka","year":"2016","unstructured":"Borecka M, Zemankova P, Vocka M, Soucek P, Soukupova J, Kleiblova P, et al. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Cancer Genet. 2016;209:199\u2013204.","journal-title":"Cancer Genet."},{"key":"612_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S2468-1253(18)30079-7","volume":"3","author":"E Fewings","year":"2018","unstructured":"Fewings E, Larionov A, Redman J, Goldgraben MA, Scarth J, Richardson S, et al. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study. Lancet Gastroenterol Hepatol. 2018;3:489\u201398.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"612_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10549-016-4085-4","volume":"161","author":"M Pritzlaff","year":"2017","unstructured":"Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS, et al. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat. 2017;161:575\u201386.","journal-title":"Breast Cancer Res Treat."},{"key":"612_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10549-018-4661-x","volume":"169","author":"F Fostira","year":"2018","unstructured":"Fostira F, Saloustros E, Apostolou P, Vagena A, Kalfakakou D, Mauri D, et al. Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer. Breast Cancer Res Treat. 2018;169:105\u201313.","journal-title":"Breast Cancer Res Treat."},{"key":"612_CR20","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-08-0210","volume":"14","author":"H Erkko","year":"2008","unstructured":"Erkko H, Dowty JG, Nikkila J, Syrjakoski K, Mannermaa A, Pylkas K, et al. Penetrance analysis of the PALB2 c.1592delT founder mutation. Clin Cancer Res. 2008;14:4667\u201371.","journal-title":"Clin Cancer Res."},{"key":"612_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1828","volume":"9","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, et al. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res. 2007;9:R83.","journal-title":"Breast Cancer Res."},{"key":"612_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10549-016-3981-y","volume":"160","author":"I Catucci","year":"2016","unstructured":"Catucci I, Casadei S, Ding YC, Volorio S, Ficarazzi F, Falanga A, et al. Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2. Breast Cancer Res Treat. 2016;160:121\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"612_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2796","volume":"12","author":"MC Southey","year":"2010","unstructured":"Southey MC, Teo ZL, Dowty JG, Odefrey FA, Park DJ, Tischkowitz M, et al. A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res. 2010;12:R109.","journal-title":"Breast Cancer Res."},{"key":"612_CR24","unstructured":"Fostira F, Walsh T, Casadei S, Lee MK, Vratimos A, Fountzilas G, et al., Combination of founder mutation screening and genomic capture using BROCA yield high rate of Loss-of-Function mutation in early onset and familial breast and ovarian cancer in Greece. ASHG meeting abstracts; 2013."},{"key":"612_CR25","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/bioinformatics\/18.6.894","volume":"18","author":"JP Reeve","year":"2002","unstructured":"Reeve JP, Rannala B. DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics. 2002;18:894\u20135.","journal-title":"Bioinformatics."},{"key":"612_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10689-009-9295-z","volume":"9","author":"L Papi","year":"2010","unstructured":"Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, et al. A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer. 2010;9:181\u20135.","journal-title":"Fam Cancer."},{"key":"612_CR27","doi-asserted-by":"publisher","first-page":"E2176","DOI":"10.1002\/humu.21478","volume":"32","author":"H Hellebrand","year":"2011","unstructured":"Hellebrand H, Sutter C, Honisch E, Gross E, Wappenschmidt B, Schem C, et al. Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Hum Mutat. 2011;32:E2176\u201388.","journal-title":"Hum Mutat."},{"key":"612_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10549-016-4034-2","volume":"161","author":"H Kim","year":"2017","unstructured":"Kim H, Cho DY, Choi DH, Oh M, Shin I, Park W, et al. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer. Breast Cancer Res Treat. 2017;161:95\u2013102.","journal-title":"Breast Cancer Res Treat."},{"key":"612_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ygyno.2019.01.027","volume":"153","author":"M Suszynska","year":"2019","unstructured":"Suszynska M, Klonowska K, Jasinska AJ, Kozlowski P. Large-scale meta-analysis of mutations identified in panels of breast\/ovarian cancer-related genes - Providing evidence of cancer predisposition genes. Gynecol Oncol. 2019;153:452\u201362.","journal-title":"Gynecol Oncol."},{"key":"612_CR30","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cam4.1376","volume":"7","author":"J Hauke","year":"2018","unstructured":"Hauke J, Horvath J, Gross E, Gehrig A, Honisch E, Hackmann K, et al. Gene panel testing of 5589 BRCA1\/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med. 2018;7:1349\u201358.","journal-title":"Cancer Med."},{"key":"612_CR31","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, et al. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123:1721\u201330.","journal-title":"Cancer."},{"key":"612_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature05609","volume":"446","author":"H Erkko","year":"2007","unstructured":"Erkko H, Xia B, Nikkila J, Schleutker J, Syrjakoski K, Mannermaa A, et al. A recurrent mutation in PALB2 in Finnish cancer families. Nature. 2007;446:316\u20139.","journal-title":"Nature."},{"issue":"8","key":"612_CR33","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/ijc.31921","volume":"144","author":"Elodie Girard","year":"2018","unstructured":"Girard E, Eon-Marchais S, Olaso R, Renault AL, Damiola F, Dondon MG, et al. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing. Int J Cancer. 2018. \n                    https:\/\/doi.org\/10.1002\/ijc.31921\n                    \n                  .","journal-title":"International Journal of Cancer"},{"key":"612_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-017-0024-8","volume":"3","author":"TP Slavin","year":"2017","unstructured":"Slavin TP, Maxwell KN, Lilyquist J, Vijai J, Neuhausen SL, Hart SN, et al. The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer. 2017;3:22.","journal-title":"NPJ Breast Cancer."},{"issue":"8","key":"612_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djy106","volume":"110","author":"Hermela Shimelis","year":"2018","unstructured":"Shimelis H, LaDuca H, Hu C, Hart SN, Na J, Thomas A, et al. Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing. J Natl Cancer Inst. 2018. \n                    https:\/\/doi.org\/10.1093\/jnci\/djy106\n                    \n                  .","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"612_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10549-014-3260-8","volume":"149","author":"T Nguyen-Dumont","year":"2015","unstructured":"Nguyen-Dumont T, Hammet F, Mahmoodi M, Tsimiklis H, Teo ZL, Li R, et al. Mutation screening of PALB2 in clinically ascertained families from the breast cancer family registry. Breast Cancer Res Treat. 2015;149:547\u201354.","journal-title":"Breast Cancer Res Treat."},{"key":"612_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33:304\u201311.","journal-title":"J Clin Oncol."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0612-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:26Z","timestamp":1684616846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-019-0612-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1038\/s10038-019-0612-6","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"8 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}